These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives. Tapia I, Alonso-Cires L, López-Tudanca PL, Mosquera R, Labeaga L, Innerárity A, Orjales A. J Med Chem; 1999 Jul 29; 42(15):2870-80. PubMed ID: 10425096 [Abstract] [Full Text] [Related]
23. 10-Ketomorphinan and 3-substituted-3-desoxymorphinan analogues as mixed kappa and micro opioid ligands: synthesis and biological evaluation of their binding affinity at opioid receptors. Zhang A, Xiong W, Bidlack JM, Hilbert JE, Knapp BI, Wentland MP, Neumeyer JL. J Med Chem; 2004 Jan 01; 47(1):165-74. PubMed ID: 14695830 [Abstract] [Full Text] [Related]
24. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles. Ioja E, Tourwé D, Kertész I, Tóth G, Borsodi A, Benyhe S. Brain Res Bull; 2007 Sep 14; 74(1-3):119-29. PubMed ID: 17683797 [Abstract] [Full Text] [Related]
26. Structure-activity relationships for SNC80 and related compounds at cloned human delta and mu opioid receptors. Knapp RJ, Santoro G, De Leon IA, Lee KB, Edsall SA, Waite S, Malatynska E, Varga E, Calderon SN, Rice KC, Rothman RB, Porreca F, Roeske WR, Yamamura HI. J Pharmacol Exp Ther; 1996 Jun 14; 277(3):1284-91. PubMed ID: 8667189 [Abstract] [Full Text] [Related]
28. Dynorphin A analogs containing a conformationally constrained phenylalanine derivative in position 4: reversal of preferred stereochemistry for opioid receptor affinity and discrimination of kappa vs. delta receptors. Aldrich JV, Zheng QI, Murray TF. Chirality; 2001 Jun 14; 13(3):125-9. PubMed ID: 11270320 [Abstract] [Full Text] [Related]
29. Synthesis and preliminary in vitro investigation of bivalent ligands containing homo- and heterodimeric pharmacophores at mu, delta, and kappa opioid receptors. Peng X, Knapp BI, Bidlack JM, Neumeyer JL. J Med Chem; 2006 Jan 12; 49(1):256-62. PubMed ID: 16392810 [Abstract] [Full Text] [Related]
31. Characterization of a novel bivalent morphinan possessing kappa agonist and micro agonist/antagonist properties. Mathews JL, Peng X, Xiong W, Zhang A, Negus SS, Neumeyer JL, Bidlack JM. J Pharmacol Exp Ther; 2005 Nov 12; 315(2):821-7. PubMed ID: 16076937 [Abstract] [Full Text] [Related]
32. Synthesis and in vitro opioid receptor functional antagonism of analogues of the selective kappa opioid receptor antagonist (3R)-7-hydroxy-N-((1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide (JDTic). Cai TB, Zou Z, Thomas JB, Brieaddy L, Navarro HA, Carroll FI. J Med Chem; 2008 Mar 27; 51(6):1849-60. PubMed ID: 18307295 [Abstract] [Full Text] [Related]
33. Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands. Zhu J, Luo LY, Li JG, Chen C, Liu-Chen LY. J Pharmacol Exp Ther; 1997 Aug 27; 282(2):676-84. PubMed ID: 9262330 [Abstract] [Full Text] [Related]
34. De novo design, synthesis, and biological activities of high-affinity and selective non-peptide agonists of the delta-opioid receptor. Liao S, Alfaro-Lopez J, Shenderovich MD, Hosohata K, Lin J, Li X, Stropova D, Davis P, Jernigan KA, Porreca F, Yamamura HI, Hruby VJ. J Med Chem; 1998 Nov 19; 41(24):4767-76. PubMed ID: 9822547 [Abstract] [Full Text] [Related]
35. Rational design, synthesis, and structure-activity relationships of aryltriazoles as novel corticotropin-releasing factor-1 receptor antagonists. Lowe RF, Nelson J, Dang TN, Crowe PD, Pahuja A, McCarthy JR, Grigoriadis DE, Conlon P, Saunders J, Chen C, Szabo T, Chen TK, Bozigian H. J Med Chem; 2005 Mar 10; 48(5):1540-9. PubMed ID: 15743196 [Abstract] [Full Text] [Related]
36. Functional interaction among opioid receptor types: up-regulation of mu- and delta-opioid receptor functions after repeated stimulation of kappa-opioid receptors. Khotib J, Narita M, Suzuki M, Yajima Y, Suzuki T. Neuropharmacology; 2004 Mar 10; 46(4):531-40. PubMed ID: 14975677 [Abstract] [Full Text] [Related]
37. Design, synthesis, and evaluation of proline and pyrrolidine based melanocortin receptor agonists. A conformationally restricted dipeptide mimic approach. Tian X, Field TB, Switzer AG, Mazur AW, Ebetino FH, Wos JA, Berberich SM, Jayasinghe LR, Obringer CM, Dowty ME, Pinney BB, Farmer JA, Crossdoersen D, Sheldon RJ. J Med Chem; 2006 Jul 27; 49(15):4745-61. PubMed ID: 16854081 [Abstract] [Full Text] [Related]
38. Ring-constrained orvinols as analogs of buprenorphine: differences in opioid activity related to configuration of C(20) hydroxyl group. Traynor JR, Guo L, Coop A, Lewis JW, Woods JH. J Pharmacol Exp Ther; 1999 Dec 27; 291(3):1093-9. PubMed ID: 10565829 [Abstract] [Full Text] [Related]
39. Synthesis and biological evaluation of 14-alkoxymorphinans. 21. Novel 4-alkoxy and 14-phenylpropoxy derivatives of the mu opioid receptor antagonist cyprodime. Spetea M, Schüllner F, Moisa RC, Berzetei-Gurske IP, Schraml B, Dörfler C, Aceto MD, Harris LS, Coop A, Schmidhammer H. J Med Chem; 2004 Jun 03; 47(12):3242-7. PubMed ID: 15163203 [Abstract] [Full Text] [Related]
40. Synthesis of 8-aminomorphans with high KOR affinity. Jonas H, Aiello D, Schepmann D, Diana P, Wünsch B. Eur J Med Chem; 2022 Feb 15; 230():114079. PubMed ID: 35033825 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]